A Novel CXCL10-Based GPI-Anchored Fusion Protein as Adjuvant in NK-Based Tumor Therapy

Niklas Muenchmeier; Sophia Boecker; Lorenz Bankel; Laura Hinz; Nicole Rieth; Constantin Lapa; Anna N. Mendler; Elfriede Noessner; Ralph Mocikat; Peter J. Nelson

doi:10.1371/journal.pone.0072749

Loading metrics

Open Access

Peer-reviewed

Research Article

A Novel CXCL10-Based GPI-Anchored Fusion Protein as Adjuvant in NK-Based Tumor Therapy

Niklas Muenchmeier,

Affiliation AG Klinische Biochemie, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
⨯
Sophia Boecker,

Affiliation AG Klinische Biochemie, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
⨯
Lorenz Bankel,

Affiliation Institut für Molekulare Immunologie, Helmholtz-Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Munich, Germany
⨯
Laura Hinz,

Affiliation AG Klinische Biochemie, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
⨯
Nicole Rieth,

Affiliation AG Klinische Biochemie, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
⨯
Constantin Lapa,

Affiliation AG Klinische Biochemie, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
⨯
Anna N. Mendler,

Affiliation Institut für Molekulare Immunologie, Helmholtz-Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Munich, Germany
⨯
Elfriede Noessner,

Affiliation Institut für Molekulare Immunologie, Helmholtz-Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Munich, Germany
⨯
Ralph Mocikat ,

Contributed equally to this work with: Ralph Mocikat, Peter J. Nelson

Affiliation Institut für Molekulare Immunologie, Helmholtz-Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Munich, Germany
⨯
Peter J. Nelson

Contributed equally to this work with: Ralph Mocikat, Peter J. Nelson

* E-mail: peter.nelson@med.uni-muenchen.de

Affiliations Institut für Molekulare Immunologie, Helmholtz-Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Munich, Germany, AG Klinische Biochemie, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
⨯

A Novel CXCL10-Based GPI-Anchored Fusion Protein as Adjuvant in NK-Based Tumor Therapy

Niklas Muenchmeier,
Sophia Boecker,
Lorenz Bankel,
Laura Hinz,
Nicole Rieth,
Constantin Lapa,
Anna N. Mendler,
Elfriede Noessner,
Ralph Mocikat,
Peter J. Nelson

Published: August 30, 2013
https://doi.org/10.1371/journal.pone.0072749

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Endothelial cells
Is the Subject Area "Endothelial cells" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
NK cells
Is the Subject Area "NK cells" applicable to this article?

Thanks for your feedback.
CHO cells
Is the Subject Area "CHO cells" applicable to this article?

Thanks for your feedback.
Chemokines
Is the Subject Area "Chemokines" applicable to this article?

Thanks for your feedback.
Cell fusion
Is the Subject Area "Cell fusion" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Recombinant proteins
Is the Subject Area "Recombinant proteins" applicable to this article?

Thanks for your feedback.